Skip to main content

Table 3 Characteristics, risk factors, and diagnostic and therapeutic procedures for stroke admissions in type 2 diabetes mellitus (T2DM) versus non-diabetic patients, according to year of study (2002, 2006, 2010, and 2014)

From: Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014)

 

2002

2006

2010

2014

T2DM

No T2DM

p value

T2DM

No T2DM

p value

T2DM

No T2DM

p value

T2DM

No T2DM

p value

N (%)a,b

10,794 (100)

10,794 (100)

NA

14,600 (100)

14,600 (100)

NA

17,283 (100)

17,283 (100)

NA

17,559 (100)

17,559 (100)

NA

Age adjusted rate per 100.000 inhabitantsa

56.27

NA

NA

69.53

NA

NA

75.79

NA

NA

71.98

NA

NA

Male sex, n (%)

5706 (52.86)

5706 (52.86)

NA

7795 (53.39)

7795 (53.39)

NA

9345 (54.07)

9345 (54.07)

NA

9581 (54.56)

9581 (54.56)

NA

Age, mean (SD)a,b

73.17 (9.75)

73.17 (9.75)

NA

74.15 (10.3)

74.15 (10.3)

NA

74.84 (10.66)

74.84 (10.66)

NA

75.35 (11.06)

75.35 (11.06)

NA

40–59 years, n (%)

1071 (9.92)

1071 (9.92)

NA

1467 (10.05)

1467 (10.05)

NA

1743 (10.09)

1743 (10.09)

NA

1865 (10.62)

1865 (10.62)

NA

60–69 years, n (%)

2386 (22.1)

2386 (22.1)

2695 (18.46)

2695 (18.46)

3027 (17.51)

3027 (17.51)

3046 (17.35)

3046 (17.35)

70–79 years, n (%)

4436 (41.1)

4436 (41.1)

5593 (38.31)

5593 (38.31)

5923 (34.27)

5923 (34.27)

5224 (29.75)

5224 (29.75)

≥ 80 years, n (%)

2901 (26.88)

2901 (26.88)

4845 (33.18)

4845 (33.18)

6590 (38.13)

6590 (38.13)

7424 (42.28)

7424 (42.28)

CCI, mean (SD)a,b

2.55 (0.74)

1.51 (0.71)

< 0.01

2.64 (0.79)

1.56 (0.75)

< 0.01

2.69 (0.81)

1.62 (0.78)

< 0.01

2.86 (0.87)

1.8 (0.84)

< 0.01

Smoking, n (%)a,b

1414 (13.1)

1566 (14.51)

0.001

2591 (17.75)

2988 (20.47)

< 0.01

3440 (19.9)

3675 (21.26)

< 0.01

3719 (21.18)

4053 (23.08)

< 0.01

Obesity, n (%)a,b

617 (5.72)

339 (3.14)

< 0.01

1171 (8.02)

622 (4.26)

< 0.01

1638 (9.48)

873 (5.05)

< 0.01

1985 (11.3)

1056 (6.01)

< 0.01

Hypertension, n (%)a,b

6470 (59.94)

5309 (49.18)

< 0.01

9841 (67.4)

7942 (54.4)

< 0.01

11,799 (68.27)

9688 (56.06)

< 0.01

11,818 (67.3)

9804 (55.83)

< 0.01

Lipid metabolism disorders, n (%)a,b

770 (7.13)

488 (4.52)

< 0.01

2449 (16.77)

1614 (11.05)

< 0.01

4960 (28.7)

3402 (19.68)

< 0.01

6801 (38.73)

4481 (25.52)

< 0.01

Renal diseases, n (%)a,b

511 (4.73)

376 (3.48)

< 0.01

988 (6.77)

625 (4.28)

< 0.01

1634 (9.45)

1009 (5.84)

< 0.01

2233 (12.72)

1410 (8.03)

< 0.01

Atrial fibrillation, n (%)a,b

2045 (18.95)

2275 (21.08)

< 0.01

3242 (22.21)

3360 (23.01)

0.065

4222 (24.43)

4395 (25.43)

0.016

4698 (26.76)

4771 (27.17)

0.314

CHF, n (%)a,b

503 (4.66)

486 (4.5)

0.579

902 (6.18)

707 (4.84)

< 0.01

1211 (7.01)

1065 (6.16)

0.001

1291 (7.35)

1039 (5.92)

< 0.01

Mechanical ventilation, n (%)a,b

254 (2.35)

358 (3.32)

< 0.01

404 (2.77)

472 (3.23)

0.013

523 (3.03)

604 (3.49)

0.010

567 (3.23)

727 (4.14)

< 0.01

HD/DP, n (%)a

32 (0.3)

18 (0.17)

0.051

58 (0.4)

31 (0.21)

0.004

73 (0.42)

51 (0.3)

0.049

99 (0.56)

47 (0.27)

< 0.01

Fibrinolysis, n (%)a,b

15 (0.14)

22 (0.2)

0.253

109 (0.75)

221 (1.51)

0.000

569 (3.29)

880 (5.09)

< 0.01

812 (4.62)

1220 (6.95)

< 0.01

Decompressive craniectomy, n (%)b

31 (0.29)

31 (0.29)

0.502

29 (0.2)

35 (0.24)

0.454

47 (0.27)

70 (0.41)

0.035

53 (0.3)

81 (0.46)

0.015

Carotid endarterectomy, n (%)a

31 (0.29)

41 (0.38)

0.227

33 (0.23)

50 (0.34)

0.064

82 (0.47)

62 (0.36)

0.088

85 (0.48)

80 (0.46)

0.694

Carotid angioplasty, n (%)a,b

0 (0)

0 (0)

NA

29 (0.2)

24 (0.16)

0.485

68 (0.39)

101 (0.58)

0.011

125 (0.71)

150 (0.85)

0.125

LHS, mean (SD)a,b

12.9 (15.1)

12.65 (16.45)

0.254

12.14 (14.63)

11.92 (15.54)

0.204

11.22 (14.56)

11.22 (15.87)

0.977

9.82 (11.75)

10.02 (12.18)

0.119

In-hospital mortality, n (%)a,b

1616 (14.97)

1692 (15.68)

0.135

2261 (15.49)

2258 (15.47)

0.960

2582 (14.94)

2568 (14.86)

0.826

2506 (14.27)

2438 (13.88)

0.272

  1. CCI charlson comorbidity index, CHF congestive heart failure, HD/DP hemodyalisis/peritoneal dialysis, LHS length of hospital stay
  2. aSignificant time trend among T2DM sufferers
  3. bSignificant time trend among non-T2DM sufferers